EXICURE, INC. Interest Income (Expense), Nonoperating, Net
EXICURE, INC. (XCUR) reported Interest Income (Expense), Nonoperating, Net of $178.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2020-03-10
- EXICURE, INC. interest income (expense), nonoperating, net for fiscal 2019 was $178.00K, a 4350.00% increase from fiscal 2018.
- EXICURE, INC. interest income (expense), nonoperating, net for fiscal 2018 was $4.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|
| 2019-12-31 | $178.00K 10-K · filed 2020-03-10 |
| 2018-12-31 | $4.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |